Home › Research › Cognitive tests and assessment
Irreversible motor impairment in young addicts--ephedrone, manganism or both?
Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Zjablov G, Asser T, Aquilonius SM.. Acta neurologica Scandinavica, 2007-06-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background Parkinsonian syndrome related to intravenous use of a "designer" psychostimulant, derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in Estonia. Objective To describe the symptomatology of four young patients, history of drug administration and chemical analysis of a drug batch. Methods Mental and motor function and quality of life were scored and ephedrone was analyzed using electrospray mass spectrometry.
What this study adds
Evidence grade: Low
This report describes four young drug addicts with irreversible parkinsonian syndrome related to intravenous use of a psychostimulant derived from pseudoephedrine using potassium permanganate. None of the four cases scored below the dementia threshold in MMSE, and this is a small descriptive case series, not a study of Alzheimer's treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., et al. (2007). Irreversible motor impairment in young addicts--ephedrone, manganism or both? Acta neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2007.00818.x
Vancouver
Sikk K, Taba P, Haldre S, Bergquist J, Nyholm D, Zjablov G, et al. Irreversible motor impairment in young addicts--ephedrone, manganism or both? Acta neurologica Scandinavica. 2007. doi:10.1111/j.1600-0404.2007.00818.x. PMID: 17511846.
BibTeX
@article{sikk2007-17511846,
author = {Sikk, K. and Taba, P. and Haldre, S. and Bergquist, J. and Nyholm, D. and Zjablov, G. and Asser, T. and Aquilonius, S. M.},
title = {{Irreversible motor impairment in young addicts--ephedrone, manganism or both?}},
journal = {Acta neurologica Scandinavica},
year = {2007},
doi = {10.1111/j.1600-0404.2007.00818.x},
pmid = {17511846},
url = {https://doi.org/10.1111/j.1600-0404.2007.00818.x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Objective To describe the symptomatology of four young patients, history of drug administration and chemical analysis of a drug batch.
- Methods Mental and motor function and quality of life were scored and ephedrone was analyzed using electrospray mass spectrometry.
- Manganese content of the final synthetic mixture was analyzed using Inductively Coupled Plasma-Atomic Emission Spectrometry.
- Results None of the four cases scored below the dementia threshold in MMSE, while other ratings (UPDRS, H&Y, PDQ-39) corresponded to disabilities seen in relatively advanced Parkinson's disease.
Why it matters
This report describes four young drug addicts with irreversible parkinsonian syndrome related to intravenous use of a psychostimulant derived from pseudoephedrine using potassium permanganate. None of the four cases scored below the dementia threshold in MMSE, and this is a small descriptive case series, not a study of Alzheimer's treatment, cure, or prevention.
Study details
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Acta neurologica Scandinavica) |
| Journal's citation record | 2 / 4 | Acta Neurologica Scandinavica: journal h-index 160 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2007 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 665 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 31.7 citations a year over 21 year(s) since 2007 |
| Impact for its field and year | 5 / 6 | Cited 30.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 2 / 4 | Cited 17 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sten‐Magnus Aquilonius: h-index 44 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Uppsala University: institution h-index 1,114 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 17511846) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1111/j.1600-0404.2007.00818.x
- PubMed: 17511846
- Original source →
- Free full text: Acta Neurologica Scandinavica →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.